Volume 2, Issue 2, March 2014, Page: 33-42
Clustering of Metabolic Syndrome and its Risk Factors among Adult Nigerians in a National Health Insurance Scheme Primary Care Clinic of a Tertiary Hospital in South-Eastern Nigeria
Gabriel Uche Pascal Iloh, Department of Family Medicine, Federal Medical Centre, Umuahia, Nigeria
Orji Udo Nnorom, Department of Family Medicine, Federal Medical Centre, Umuahia, Nigeria
Patrick Uchenna Njoku, Department of Family Medicine, Federal Medical Centre, Umuahia, Nigeria
Godwin Oguejiofor Chukwuebuka Okafor, Department of Community Medicine, Federal Medical Centre, Umuahia, Nigeria
Augustine Obiora Ikwudinma, Department of Family Medicine, Federal Teaching Hospital Abakiliki, Nigeria
Received: Jan. 26, 2014;       Published: Mar. 10, 2014
DOI: 10.11648/j.ajhr.20140202.11      View  3136      Downloads  170
Abstract
Background: The increasing incidence of MetS in Nigeria is a national health problem. As the case detection of MetS increases in different Nigerian populations evaluating for its clusters among NHIS patients in primary care setting is an important health service challenge that is often overlooked. Aim: This study was designed to determine the prevalence of MetS and its risk factors among adult Nigerians in a NHIS primary care clinic of a tertiary hospital in South-eastern Nigeria.Materials and Methods: This was a primary care clinic-based cross sectional study carried out on 210 adult NHIS patients using International Diabetes Federation(IDF) criteria: An Individual was considered to have MetS in the presence of waist circumference(WC) ≥94 cm for men and ≥80 cm for women plus any two or more of the following: systolic and/or diastolic blood pressure ≥130/85 mmHg and/or hypertension on treatment; fasting blood glucose ≥ 100mg/dL and/or diabetes mellitus on treatment; triglyceride level ≥150 mg/dL and/or hypertriglyceridaemia on treatment and high density lipoprotein(HDL-C) cholesterol <40mg/dL for men or <50 mg/dL for women and/or HDL-C dyslipidaemia on treatment. Data was collected using pretested, structured and researcher administered questionnaire. Results: The prevalence of MetS was 38.6%. MetS was significantly associated with old age≥40 years(p=.002), female sex(p=.044), family history of hypertension(p=.036) and physical inactivity(p=.001). The most significant predictor of MetS was physical inactivity.[OR=3.09 , CI=(1.81-10.06), p=.001]. The patients with MetS were three times more likely to be physically inactive compared to their non-MetS counterparts. Conclusion: This study has shown that MetS exist among the study population and was significantly associated with old age ≥40 years, female sex, family history of hypertension and physical inactivity. The most significant predictor variable was physical inactivity. NHIS patients in the primary care clinic should be the focus of primary and secondary preventive interventions for MetS.
Keywords
Adult Nigerians, Mets, NHIS, Prevalence, Primary Care Clinic, Risk Factors
To cite this article
Gabriel Uche Pascal Iloh, Orji Udo Nnorom, Patrick Uchenna Njoku, Godwin Oguejiofor Chukwuebuka Okafor, Augustine Obiora Ikwudinma, Clustering of Metabolic Syndrome and its Risk Factors among Adult Nigerians in a National Health Insurance Scheme Primary Care Clinic of a Tertiary Hospital in South-Eastern Nigeria, American Journal of Health Research. Vol. 2, No. 2, 2014, pp. 33-42. doi: 10.11648/j.ajhr.20140202.11
Reference
[1]
Alberti KG, Eckel RH, Grundy SM. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-45.
[2]
Cornier MA, Dabela D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008; 29: 777-822.
[3]
Kelliny C, William J, Riesen W, Paccaud F, Bovet P. Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol 2008; 7: 27.
[4]
Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis 2007; 193: 70-76.
[5]
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
[6]
Alshehri AM. Metabolic syndrome and cardiovascular risk. J Fam Community Med 2010; 17: 73-78
[7]
Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in native African type 2 diabetic patients. J Natl Med Assoc 2005; 97: 557-563.
[8]
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
[9]
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung and Blood Institute scientific statement. Circulation 2005; 112: 2735-2752.
[10]
Grundy SM, Brewer FIB, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
[11]
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
[12]
Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9:237-252.
[13]
Balkau B, Charles MA. Comment on the provisional report from THE WHO CONSULTATION. European Group for the study of Insulin Resistance(EGIR) Diabet Med 1999; 16: 442-443.
[14]
Akintunde AA, Ayodele OE, Akinwusi PO, Opadijo GO. Metabolic syndrome: Comparison of occurrence using three definitions in hypertensive patients. Clin Med Res 2011; 9: 26-31.
[15]
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
[16]
Al-Nozha M, Al-Khadra A, Arafah MR, Al-Maatouq MA, Khalil MZ, Khan NB, et al. Metabolic syndrome in Saudi Arabia. Saudi Med J 2005; 26: 1918-1925.
[17]
Pemminati S, Prabha Adhikari MR, Pathak R, Pai MR. Prevalence of metabolic syndrome(METS) using IDF 2005 guidelines in a semi urban south Indian(Boloor Diabetes Study) population of Mangalore. J Assoc Physicians India 2010; 58: 674-677.
[18]
Gyakobo M, Amoah AGB, Martey-Marbell D, Snow RC. Prevalence of the metabolic syndrome in a rural population in Ghana. BMC Endocr Disord 2012; 12: 25.
[19]
Tran A, Gelaye B, Girma B, Lemma S, Berhane Y, Bekele T, et al. Prevalence of metabolic syndrome among working adults in Ethiopia. Int J Hypertens 2011.
[20]
Ulasi II, Ijoma CK, Onodugo OD. A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria. BMC Health Serv Res 2010; 10: 71
[21]
Adediran O, Akintunde AA, Edo AE, Opadijo OG, araoye AM. Impact of urbanization and gender on frequency of metabolic syndrome among native Abuja settlers in Nigeria. J Cardiovasc Dis Res 2012; 3: 191-196.
[22]
Ismail MF. Metabolic syndrome among obese Qataris attending primary health care centers in Doha. 2010. J Fam Community Med 2012; 19: 7-11.
[23]
Termizy HM, Matauzy M. Metabolic syndrome and its characteristics among obese patients attending an obesity clinic. Singpore Med J 2009; 50: 390-4.
[24]
Marchesini G, Melchionda N, Apolone G, Cuzzolaro M, Mannucci E, Grossi E. The metabolic syndrome in treatment seeking obese persons. Metabolism 2004; 53: 435 -40.
[25]
2Surana SP, Shah DB, Gala K, Hoskote SS, Gill N, Joshi AR, et al. Prevalence of metabolic syndrome in an Indian population using the NCEP ATP III. J Assoc Physicians India 2008; 56: 865-8.
[26]
Alebiosu Co, Odusan BO. Metabolic Syndrome in subjects with type 2 diabetes mellitus J Natl Med. Assoc. 2004, 96: 817 – 21.
[27]
Puepet FH, Uloko A, Akogu IY, Aniekwensi E. Prevalence of the metabolic syndrome among patients with type 2 diabetes mellitus in urban North-Central Nigeria. Afr J Endocrinol Metab 2009; 8: 10-12
[28]
Meigs JB, Larson MG, D’Agostino RB. Coronary artery calcification in type 2 diabetes and insulin resistance. The Famingham Offspring Study. Diabetes Care 2002; 25: 1313-19.
[29]
Bonora E, Kiechi S, Willet J, Oberholienzer F, Egger G, Bonadonna RC, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: Prospective data from the Bruneck study. Diabetes Care 2003; 26: 1251-1257.
[30]
Liu S, Manson JE. Dietary carbohydrates, physical inactivity, obesity and the ‘metabolic syndrome’ as predictors of coronary heart disease. Curr Opin Lipidol 2001; 12: 395-404.
[31]
Park HS, Oh SW, Cho WH, Kim YS. The metabolic syndrome and associated lifestyle factor among South Korean adults. Int J Epidemiol 2004; 33: 328-336.
[32]
Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad(hyperinsulinemia, hyperapolipoprotein B, small dense LDL) in men. Circulation 2000; 102: 179-184.
[33]
Okeahialam BN, Ogbonna C, Otokwula AE, Joseph DE, Chuwak EK, Isiguzoro IO. Cardiovascular Epidemiological Transition in a Rural Habitat of Nigeria: The Case of Mangu Local Government Area. West Afr J Med 2012; 31: 14-18.
[34]
Araoye MO. Sample size determination. Research Methodology with Statistics for Health and Social Sciences, Ilorin, Nathadex Publishers, 2004; p.115-121.
[35]
Iloh GUP, Ikwudinma AO Abdominal obesity in adult Nigerian Africans: prevalence and co- occurrence with cardio-metabolic risk factors in a resource poor setting of a rural hospital in Eastern Nigeria. American Journal of Health Research 2013; 1: 73-80.
[36]
Iloh GUP, Amadi AN, Ikwudinma AO, Njoku PU. Prevalence and Family Biosocial Predictors of Abdominal Obesity among Adult Nigerian Africans in a Resource Constrained Setting of a Rural Hospital in Eastern Nigeria. European Journal of Preventive Medicine. 2013; 1:70-78.
[37]
Iloh GP, Ikwudinma AO, Obiegbu NP. Obesity and its cardio-metabolic co-morbidities among adult Nigerians in a primary care clinic of a tertiary hospital in South-Eastern Nigeria. J Fam Med Primary Care 2013; 2: 20-26
[38]
WHO. Survey of the STEPwise approach for the survellaince of risk factors for non-communicable diseases, Brazzaville, WHO, Region office for Africa, 2007.
[39]
Iloh GUP, Chuku A, Obiegbu NP, Ofoedu JN, Ikwudinma AO. Frequency of cardiovascular risk factors in adult Nigerians with family history of non-communicable cardiovascular disease in a primary care clinic of a tertiary hospital in a resource-constrained environment of Eastern Nigeria. American Journal of Health Research 2013; 1(1): 17-25.
[40]
Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. Prevalence of cardiometabolic risk factors among a rural Yoruba South Western Nigerian population. A population-based survey. Cardiovasc J Afr 2010; 21: 26-31.
[41]
Gundogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A. et al. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity and dyslipidaemia. Metab Syndr Relat Disord 2009; 7: 427-34.
[42]
Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, et al. Genome-wide mapping of human loci for essential hypertension. Lancet 2003; 361: 2118-2123.
[43]
Goldstein IB, Shapiro D, Guthrie D. Ambulatory blood pressure and family history of hypertension in healthy men and women. Am J Hypertens 2006; 19: 486-491.
[44]
Yoon PW, Scheuner MT, Khoury MJ. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003; 24:128-135.
[45]
Ugwuja EI, Ogbonna NC, Nwibo AN, Onimawo IA. Overweight and obesity, lipid profile and atherogenic indices among civil servants in Abakiliki, South Eastern Nigeria. Ann Med Health Sci Res 2013; 3: 13-18.
[46]
Mogrel V, Mwinlenaa PP, Oladele J, Amalba A. Impact of physical activity levels and diet on central obesity among civil servants in Tamale metropolis. J Med Biomed Sci 2012; 1:1-9.
[47]
Dancy C, Lohsoonthorn V, Williams MA. Risk of dyslipidaemia in relation to level of physical activity among Thai professionals and office workers. Southeast Asian J Trop Med Public Health 2008; 39: 932-941.
[48]
WHO. Global strategy on diet, physical activity and health. Bulletins of the WHO 2006; 5: 16-18.
[49]
Lee IM. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380: 219-29.
[50]
Katzmarzyk PE, Church TS, Blair SN. Cardio-respiratory fitness attenuates the effects of the metabolic syndrome on all cause and cardiovascular disease mortality in men. Arch Intern Med 2004; 164: 1092-7.
[51]
Lakshminarayanan S, Bala SM, Ramanujam M, Kannan G. Effectiveness of physical activity promotion in blood pressure and blood sugar reduction: A community-based intervention study in rural south India. J Fam Community Med 2012; 19: 81-87.
[52]
Sobngwi E, Mbanya JC, Unwin NC. Physical activity and its relationship with obesity, hypertension and diabetes in urban and rural Cameroon. Int J Obes.Relat Metab Disord 2003; 26: 1009-16.
[53]
Iloh GUP, Obiegbu NP, Abali Chuku, Ikwudinma AO. Predictors of limitations of physical activities of daily living among geriatric Nigerians with musculoskeletal disorders in under-resourced environment of a primary care clinic of a tertiary hospital in Eastern Nigeria. European Journal of Preventive Medicine 2013; 1: 37-45
Browse journals by subject